Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd.

Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd. was founded on December 30th 2006. Lonzeal’s current core business is research and development, production and sales of anti-AIDS and hepatitis B drugs. We are now one of the most competitive manufacturers of anti-retrovirus (ARV for HIV and HBV) drugs in China., with product registration at international drug authorities including WHOPQ, China, India, Russia, Brazil and South Africa. Our product line covers APIs, intermediates and finished products, supplying to esteemed pharmaceutical companies both domestic and international. GMP Manufacturing site is located at National Biopharmaceuticals Industrial Zone in Shenze, Hebei Province of China, accompanied with R&D center in Shijiazhuang City. Lamivudine Tablets, Tenofovir Disoproxil Fumarate Tablets, Tenofovir Alafenamide Fumarate Tablets, Pregabalin Capsules and Paroxetine Hydrochloride Tablets have been approved by China NMPA. Lamivudine tablets are the first product in China to pass the consistency evaluation. Following finished pharmaceutical products will be marketing soon: Tenofovir Alafenamide Hemifumarate (TAF)/Emtricitabine Tablet, Esomeprazole Magnesium Enteric-Coated Tablets, Tadalafil Tablets and Vonoprazan Fumarate Tablets.